Elastase and Tryptase Govern TNFα-Mediated Production of Active Chemerin by Adipocytes

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Parlee, Sebastian D ^b   McNeil, Jenna O ^a   Muruganandan, Shanmugam ^b   Sinal, Christopher J ^b   Goralski, Kerry B ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; APROTININ; BESTATIN; CHEMERIN; CHEMOKINE RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ELASTASE; MESSENGER RNA; PROTEINASE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FIBRINOLYSIS; IN VITRO STUDY; LYMPHOCYTE; MAST CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN SECRETION; RNA ISOLATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CHEMOTACTIC FACTORS; CULTURE MEDIA; FIBRINOLYSIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUCINE; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PANCREATIC ELASTASE; PROTEASE INHIBITORS; PROTEOLYSIS; RECEPTORS, G-PROTEIN-COUPLED; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870797298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051072     Document Type: Article

References (77)

1. Ernst MC, Issa M, Goralski KB, Sinal CJ, (2010) Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151: 1998-2007.
2. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282: 28175-28188.
3. Muruganandan S, Roman AA, Sinal CJ, (2010) Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res 25: 222-234.
4. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, et al. (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109: 3625-3632.
5. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, et al. (2009) Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58: 2731-2740.
6. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, et al. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 582: 573-578.
7. Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, et al. (2005) Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 201: 509-515.
8. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198: 977-985.
9. Zabel BA, Silverio AM, Butcher EC, (2005) Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 174: 244-251.
10. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148: 4687-4694.
11. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 94: 3085-3088.
12. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, et al. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161: 339-344.
13. Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, et al. (2009) Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 58: 1971-1977.
14. Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, Rotellar F, et al. (2011) Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-alpha stimulates mRNA levels of chemerin in visceral adipocytes from obese patients. Surg Obes Relat Dis.
15. Chakaroun R, Raschpichler M, Kloting N, Oberbach A, Flehmig G, et al. (2011) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism.
16. Tonjes A, Fasshauer M, Kratzsch J, Stumvoll M, Bluher M, (2010) Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One 5: e13911.
17. Yang M, Yang G, Dong J, Liu Y, Zong H, et al. (2010) Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Investig Med 58: 883-886.
18. El-Mesallamy HO, El-Derany MO, Hamdy NM (2011) Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med.
19. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH, (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 17: 115-130.
20. Dong B, Ji W, Zhang Y, (2011) Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50: 1093-1097.
21. Gao X, Mi S, Zhang F, Gong F, Lai Y, et al. (2011) Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol 10: 87.
22. Hah YJ, Kim NK, Kim MK, Kim HS, Hur SH, et al. (2011) Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease. Diabetes Metab J 35: 248-254.
23. Yan Q, Zhang Y, Hong J, Gu W, Dai M, et al. (2012) The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 41: 281-288.
24. Yoo HJ, Choi HY, Yang SJ, Kim HY, Seo JA, et al. (2012) Circulating chemerin level is independently correlated with arterial stiffness. J Atheroscler Thromb 19: 59-66; discussion 67-58.
25. Mussig K, Staiger H, Machicao F, Thamer C, Machann J, et al. (2009) RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. Metabolism 58: 519-524.
26. Stejskal D, Karpisek M, Hanulova Z, Svestak M, (2008) Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152: 217-221.
27. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, et al. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 280: 34661-34666.
28. Du XY, Zabel BA, Myles T, Allen SJ, Handel TM, et al. (2009) Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets. J Biol Chem 284: 751-758.
29. Wittamer V, Gregoire F, Robberecht P, Vassart G, Communi D, et al. (2004) The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem 279: 9956-9962.
30. Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M, et al. (2005) Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 175: 487-493.
31. Kulig P, Kantyka T, Zabel BA, Banas M, Chyra A, et al. (2011) Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol 187: 1403-1410.
32. Guillabert A, Wittamer V, Bondue B, Godot V, Imbault V, et al. (2008) Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J Leukoc Biol 84: 1530-1538.
33. John H, Hierer J, Haas O, Forssmann WG, (2007) Quantification of angiotensin-converting-enzyme-mediated degradation of human chemerin 145-154 in plasma by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Anal Biochem 362: 117-125.
34. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, et al. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 205: 767-775.
35. Song SH, Fukui K, Nakajima K, Kozakai T, Sasaki S, et al. (2010) Cloning, expression analysis, and regulatory mechanisms of bovine chemerin and chemerin receptor. Domest Anim Endocrinol 39: 97-105.
36. Du XY, Leung LL, (2009) Proteolytic regulatory mechanism of chemerin bioactivity. Acta Biochim Biophys Sin (Shanghai) 41: 973-979.
37. Luangsay S, Wittamer V, Bondue B, De Henau O, Rouger L, et al. (2009) Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 183: 6489-6499.
38. Parlee SD, Ernst MC, Muruganandan S, Sinal CJ, Goralski KB, (2010) Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}. Endocrinology 151: 2590-2602.
39. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
40. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, et al. (2008) The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci U S A 105: 64-69.
41. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, et al. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201: 713-722.
42. Fritz H, Wunderer G, (1983) Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung 33: 479-494.
43. Zollner H (1993) Handbook of enzyme inhibitors. Weinheim, Federal Republic of Germany; New York: VCH. 2 v. (1065 p.) p.
44. Issa ME, Muruganandan S, Ernst MC, Parlee SD, Zabel BA, et al. (2012) Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. Am J Physiol Cell Physiol.
45. Muruganandan S, Parlee SD, Rourke JL, Ernst MC, Goralski KB, et al. (2011) Chemerin, a Novel Peroxisome Proliferator-activated Receptor {gamma} (PPAR{gamma}) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis. J Biol Chem 286: 23982-23995.
46. Bondue B, Wittamer V, Parmentier M, (2011) Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev 22: 331-338.
47. Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, et al. (1997) Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol 109: 91-95.
48. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, et al. (2003) Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett 555: 495-499.
49. Pham CT, (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6: 541-550.
50. Lecaille F, Kaleta J, Bromme D, (2002) Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 102: 4459-4488.
51. Lopez-Otin C, Bond JS, (2008) Proteases: multifunctional enzymes in life and disease. J Biol Chem 283: 30433-30437.
52. Hou WS, Li W, Keyszer G, Weber E, Levy R, et al. (2002) Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 46: 663-674.
53. Huet G, Flipo RM, Colin C, Janin A, Hemon B, et al. (1993) Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum 36: 772-780.
54. Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, et al. (1997) Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol 36: 735-743.
55. Naour N, Rouault C, Fellahi S, Lavoie ME, Poitou C, et al. (2010) Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation. J Clin Endocrinol Metab 95: 1861-1868.
56. Taleb S, Cancello R, Clement K, Lacasa D, (2006) Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 147: 4950-4959.
57. Taleb S, Lacasa D, Bastard JP, Poitou C, Cancello R, et al. (2005) Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 19: 1540-1542.
58. Seki T, Miyasu T, Noguchi T, Hamasaki A, Sasaki R, et al. (2001) Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes. J Cell Physiol 189: 72-78.
59. Lehr S, Hartwig S, Lamers D, Famulla S, Muller S, et al. (2012) Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 11: M111 010504.
60. Macotela Y, Emanuelli B, Mori MA, Gesta S, Schulz TJ, et al. (2012) Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 61: 1691-1699.
61. Reed CE, Kita H (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114: 997-1008; quiz 1009.
62. Taggart C, Coakley RJ, Greally P, Canny G, O'Neill SJ, et al. (2000) Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol 278: L33-41.
63. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL, (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95: 244-250.
64. Tetley TD, (2002) Macrophages and the pathogenesis of COPD. Chest 121: 156S-159S.
65. Bonnart C, Deraison C, Lacroix M, Uchida Y, Besson C, et al. (2010) Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 120: 871-882.
66. Adkison AM, Raptis SZ, Kelley DG, Pham CT, (2002) Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 109: 363-371.
67. Le QT, Min HK, Xia HZ, Fukuoka Y, Katunuma N, et al. (2011) Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C. J Immunol. 186: 7136-7143.
68. Heymann E, Mentlein R, Nausch I, Erlanson-Albertsson C, Yoshimoto T, et al. (1986) Processing of pro-colipase and trypsinogen by pancreatic dipeptidyl peptidase IV. Biomed Biochim Acta 45: 575-584.
69. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, et al. (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60: 1917-1925.
70. Mikhail N, (2011) Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes. Curr Drug Saf 6: 304-309.
71. Zhao L, Yamaguchi Y, Sharif S, Du XY, Song JJ, et al. (2011) Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial and Cerebrospinal Fluids but Not in Plasma. J Biol Chem 286: 39520-39527.
72. Taylor A, (1993) Aminopeptidases: structure and function. FASEB J 7: 290-298.
73. Ramirez M, Prieto I, Alba F, Vives F, Banegas I, et al. (2008) Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis. Heart Fail Rev 13: 339-353.
74. Kanayama N, Kajiwara Y, Goto J, el Maradny E, Maehara K, et al. (1995) Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 57: 129-134.
75. Hui KS, Wang YJ, Lajtha A, (1983) Purification and characterization of an enkephalin aminopeptidase from rat brain membranes. Biochemistry 22: 1062-1067.
76. Ress C, Tschoner A, Engl J, Klaus A, Tilg H, et al. (2010) Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest 40: 277-280.
77. Buxbaum E (2007) Fundamentals of protein structure and function. New York; London: Springer. xi, 367 p.